Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cancer Advances

Cancer Advances?uq=PEM9b6PF
2008 FOUNDED
PRIVATE STATUS
Buyout/LBO LATEST DEAL TYPE
1 INVESTORS
Description

Developer of drugs designed to treat gastrointestinal cancers. The company's drugs help to enhance the immune system of the patients and prevent the progression of their disease, enabling healthcare providers to improve the lives of the patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Westpark Corporate Center
  • 4364 South Alston Avenue, Suite 210
  • Durham, NC 27713
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cancer Advances’s full profile, request a free trial.

Cancer Advances Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Buyout/LBO Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Cancer Advances Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Cato BioVentures Corporate Venture Capital Majority 000 0000 000000 0

Cancer Advances Executive Team (3)

Name Title Board
Seat
Contact
Info
Allen Cato Ph.D Senior Vice President of Drug Development
Allen Cato MD Co-Founder, Chief Executive Officer & Chief Medical Officer
Lynda Sutton President